Comparative Pharmacology
Head-to-head clinical analysis: FLAC versus PREDNISONE INTENSOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLAC versus PREDNISONE INTENSOL.
FLAC vs PREDNISONE INTENSOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FLAC (Fluorouracil) is a pyrimidine analog that inhibits thymidylate synthase, blocking DNA synthesis. It is converted to active metabolites (FdUMP, FUTP) that disrupt RNA function and DNA replication.
Prednisone is a prodrug that is converted to prednisolone, which binds to the glucocorticoid receptor, modulating gene expression to produce anti-inflammatory and immunosuppressive effects by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis, and suppressing cytokine production.
Adults: 40 mg orally twice daily.
5-60 mg orally once daily or divided twice daily, titrated to response.
None Documented
None Documented
2-4 hours; prolonged in renal impairment (up to 12 hours)
2-4 hours (terminal) for prednisone; prednisolone half-life 2-4 hours. Clinical context: shorter than anti-inflammatory effect due to delayed receptor-mediated action.
Renal: 70% unchanged; Fecal: 20%; Biliary: 10%
Renal: <30% unchanged; major metabolites (prednisolone, 20-dihydroprednisolone) conjugated and excreted in urine. Fecal: <10%.
Category C
Category D/X
Corticosteroid
Corticosteroid